Literature DB >> 30246357

Intraoperative S-ketamine for the reduction of opioid consumption and pain one year after spine surgery: A randomized clinical trial of opioid-dependent patients.

Rikke Vibeke Nielsen1, Jonna Storm Fomsgaard1, Lone Nikolajsen2, Jørgen Berg Dahl3, Ole Mathiesen4.   

Abstract

BACKGROUND: We aimed to explore the effect of intraoperative S-ketamine on analgesic consumption and pain one year after spine surgery in chronic opioid-dependent patients undergoing spinal fusion surgery.
METHODS: Single-centre, randomized, blinded trial of 147 patients. INTERVENTION: Perioperative S-ketamine bolus 0.5 mg/kg followed by S-ketamine 0.25 mg kg-1  hr-1 infusion or placebo. MAIN OUTCOMES: Analgesic use, pain (visual analogue scale 0-100 mm [VAS]) and labour market attachment one year after surgery assessed by written questionnaires.
RESULTS: Response rate was 67%. One year after surgery, the daily use of oral morphine equivalents was lower in the ketamine group versus the placebo group: 0 (0-20) mg versus 20 (0-62) mg, (p = 0.02), and fewer patients had a daily use of any analgesics in the ketamine group versus placebo group, 42% (95% CI 23-61) versus 74% (95% CI 58-87), (p = 0.04). Mobilization pain was lower in the ketamine group compared to the placebo group: Median difference 17 mm (95% CI -30 to -3), (p = 0.02). Pain at rest was lower in the ketamine group compared to the placebo group with median difference: 13 mm (95% CI -23 to -3), (p = 0.01). Further, labour market attachment was better in the ketamine group, (p = 0.02).
CONCLUSION: Intraoperative ketamine may reduce analgesic use, pain, and improve labour market attachment one year after spine surgery in a chronic opioid-dependent population. SIGNIFICANCE: This randomized clinical trial shows that intraoperative ketamine may reduce opioid use and pain and improve labour market attachment one year after spine surgery in an opioid-dependent population.
© 2018 European Pain Federation - EFIC®.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30246357     DOI: 10.1002/ejp.1317

Source DB:  PubMed          Journal:  Eur J Pain        ISSN: 1090-3801            Impact factor:   3.931


  8 in total

Review 1.  [Prediction and prevention of chronic postoperative pain].

Authors:  Esther Pogatzki-Zahn
Journal:  Schmerz       Date:  2021-01-20       Impact factor: 1.107

Review 2.  Ketamine for the Treatment of Chronic Pain: A Comprehensive Review.

Authors:  Jacob E Israel; Samantha St Pierre; Emily Ellis; Josephine S Hanukaai; Nazir Noor; Giustino Varrassi; Markus Wells; Alan D Kaye
Journal:  Health Psychol Res       Date:  2021-07-10

Review 3.  Management of Opioid-Tolerant Patients with Acute Pain: Approaching the Challenges.

Authors:  Pamela E Macintyre; Lindy J Roberts; Christine A Huxtable
Journal:  Drugs       Date:  2020-01       Impact factor: 9.546

4.  Intraoperative ketamine may increase risk of post-operative delirium after complex spinal fusion for adult deformity correction.

Authors:  Aladine A Elsamadicy; Lefko T Charalambous; Amanda R Sergesketter; Nicolas Drysdale; Syed M Adil; Issac G Freedman; Theresa Williamson; Adam J Kundishora; Joaquin Camara-Quintana; Muhammad M Abd-El-Barr; C Rory Goodwin; Isaac O Karikari
Journal:  J Spine Surg       Date:  2019-03

5.  Opioid Use After Common Sports Medicine Procedures: A Systematic Review.

Authors:  Ujash Sheth; Mitesh Mehta; Fernando Huyke; Michael A Terry; Vehniah K Tjong
Journal:  Sports Health       Date:  2020-04-09       Impact factor: 3.843

6.  Subanaesthetic dose of esketamine during induction delays anaesthesia recovery a randomized, double-blind clinical trial.

Authors:  Cao Zhang; Jiangqin He; Qinye Shi; Fangping Bao; Jianhong Xu
Journal:  BMC Anesthesiol       Date:  2022-05-09       Impact factor: 2.376

Review 7.  Opioid Sparing Analgesics in Spine Surgery.

Authors:  Logan A Reed; Mihir Patel; Kevin Luque; Steven M Theiss
Journal:  Adv Orthop       Date:  2022-07-30

Review 8.  Helpful or Harmful? The Therapeutic Potential of Medications with Varying Degrees of Abuse Liability in the Treatment of Substance Use Disorders.

Authors:  Bradford Martins; Will Rutland; Joao P De Aquino; Benjamin L Kazer; Melissa Funaro; Marc N Potenza; Gustavo A Angarita
Journal:  Curr Addict Rep       Date:  2022-08-15
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.